Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
T-box 2
(
TBX2
) is a transcription factor involved in mammary development and is known to be overexpressed in a subset of aggressive breast cancers.
TBX2
has previously been shown to repress growth control genes such as p14(ARF) and p21(WAF1/cip1). In this study we show that
TBX2
drives proliferation in breast cancer cells and this is abrogated after
TBX2
small interfering RNA (siRNA) knockdown or after the expression of a dominant-negative
TBX2
protein. Using microarray analysis we identified a large cohort of novel
TBX2
-repressed target genes including the breast
tumour suppressor
NDRG1 (N-myc downregulated gene 1). We show that
TBX2
targets NDRG1 through a previously undescribed mechanism involving the recruitment of early growth response 1 (EGR1). We show EGR1 is required for the ability of
TBX2
to repress NDRG1 and drive cell proliferation. We show that
TBX2
interacts with EGR1 and that
TBX2
requires EGR1 to target the NDRG1 proximal promoter. Abrogation of either
TBX2
or EGR1 expression is accompanied by the upregulation of cell senescence and apoptotic markers. NDRG1 can recapitulate these effects when transfected into
TBX2
-expressing cells. Together, these data identify a novel mechanism for
TBX2
-driven oncogenesis and highlight the importance of NDRG1 as a growth control gene in breast tissue.
...
PMID:T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells. 2034 48